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Available online 26 August 2016This study investigated associations between objectively measured physical activity (PA) with sarcopenia and
sarcopenic obesity in older British men. Participants were men aged 70–92 years (n = 1286) recruited from
UK Primary Care Centres. Outcomes included (i) sarcopenia, deﬁned as low muscle mass (lowest two ﬁfths of
the mid-upper arm muscle circumference distribution) accompanied by low muscular strength (hand grip
strength b30 kg) or low physical performance (gait speed ≤ 0.8 m/s); (ii) severe sarcopenia, required all three
conditions; (iii) sarcopenic obesity deﬁned as sarcopenia or severe sarcopenia and a waist circumference of
N102 cm. Independent variables included time spent in PA intensities measured by GT3x accelerometers, worn
during one week in 2010–12. Multinomial regression models were used for cross-sectional analyses relating
PA and sarcopenia. In total, 14.2% (n = 183) of men had sarcopenia and a further 5.4% (n = 70) had severe
sarcopenia. 25.3% of sarcopenic or severely sarcopenic men were obese. Each extra 30 min per day of moder-
ate-to-vigorous PA (MVPA) was associated with a reduced risk of severe sarcopenia (relative risk [RR] 0.53,
95% conﬁdence interval [CI] 0.30, 0.93) and sarcopenic obesity (RR 0.47 [95% CI 0.27, 0.84]). Light PA (LPA)
and sedentary breaks were marginally associated with a reduced risk of sarcopenic obesity. Sedentary time
was marginally associated with an increased risk of sarcopenic obesity independent of MVPA (RR 1.18 [95% CI
0.99, 1.40]). MVPAmay reduce the risk of severe sarcopenia and sarcopenic obesity among older men. Reducing
sedentary time and increasing LPA and sedentary breaks may also protect against sarcopenic obesity.Care & Popul
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Muscle mass1. Introduction
Normal aging involves important changes to body composition, in-
cluding decreased muscle mass and increased fat mass (Zamboni et
al., 2008). The age-related loss of muscle mass combined with loss of
muscular strength and/or function is referred to as sarcopenia and oc-
curs in up to 29% of community-dwelling older adults (Cruz-Jentoft et
al., 2014). Sarcopenia is associated with an increased risk of frailty, dis-
ability and mortality in older adults (Waters et al., 2010; Landi et al.,
2013). The co-occurrence of sarcopenia and obesity, deﬁned as
sarcopenic obesity, may heighten effects on health outcomes (Atkins
et al., 2014a; Dominguez & Barbagallo, 2007; Zamboni et al., 2008). As
physical activity (PA) is associated with lower fat mass and increased
muscular strength and function (Bann et al., 2015; Shephard et al.,
2013; Kuh et al., 2005), it may signiﬁcantly reduce the risk of sarcopenia
and sarcopenic obesity, making it one of themost important modiﬁableation Health, UCL
en access article underrisk factors. Resistance training is particularly beneﬁcial for improving
muscular strength and function in the elderly (Cruz-Jentoft et al., 2014).
A number of cross-sectional and longitudinal studies have investi-
gated the association between PA and sarcopenia using predominantly
self-reported measures of PA. These studies have consistently shown
that higher overall levels of PA are associated with a reduced risk of
sarcopenia and sarcopenic obesity (Ryu et al., 2013; Kim et al., 2013;
Atkins et al., 2014a; Hughes et al., 2001). One study reported that the
risk of sarcopenia and sarcopenic obesity can be reduced by up to 74%
and 73% in regularly active men, respectively (Ryu et al., 2013).
Although self-report measures provide useful information on context
of PA, objective measures allow more reliable estimates of volume and
intensity. While studies using objective measures are few (Shephard
et al., 2013; Bann et al., 2014; Park et al., 2010) they appear to conﬁrm
previous ﬁndings using self-reported PA. A recent prospective study
showed that high levels of objectivelymeasuredwalking approximately
halved the risk of sarcopenia (Shephard et al., 2013). The authors also
observed additional reductions in risk with PA at a moderate-to-vigor-
ous intensity. Other studies report positive associations between PA
and the individual components of sarcopenia, including muscle mass
(Abe et al., 2012; Bann et al., 2014), muscular strength and functionthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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speciﬁc intensities of objectively measured PA with both sarcopenia
and sarcopenic obesity has not beenwell explored. Studies have not ad-
dressedwhether differences in sedentary time, breaks in sedentary time
and light PA (LPA) are associatedwith these conditions, which is impor-
tant as older adults spend themajority of their time sedentary or in LPA.
In addition, the association of PA with severe sarcopenia (low muscle
mass accompanied by lowmuscular strength and physical performance
(Cruz-Jentoft et al., 2010)) has not yet been investigated. Therefore the
primary aim of this study was to investigate how objectively measured
PA levels of different intensities are associated with sarcopenia, severe
sarcopenia and sarcopenic obesity in community-dwelling older British
men. We also investigated whether self-reported resistance training
was associated with these conditions. Finally, we explored associations
between different intensities of PA with the individual components of
sarcopenia and sarcopenic obesity, namely muscle mass, physical per-
formance, strength and obesity.
2. Methods
2.1. Participants
The British Regional Heart Study (BRHS) is an ongoing prospective
cohort study involving 7735 men from 24 towns in Great Britain. The
cohort were recruited from primary care practices and initially exam-
ined in 1978–80 aged 40 to 59 years. In 2010–12, all 3137 surviving co-
hort members aged 72–91 years were invited to attend a physical
examination, complete a lifestyle and medical history questionnaire
and have their PA levels measured objectively.
3. Exposure measures: physical activity
3.1. Accelerometry data
Participants were instructed to wear a GT3X accelerometer
(Actigraph, Pensacola, Florida, USA) over the hip for 7 days, duringwak-
ing hours, removing only for water-based activities. Accelerometer data
were treated using standard techniques described previously (Jefferis et
al., 2014). Non-wear timewas identiﬁed and excluded using the R pack-
age “Physical Activity” (Choi et al., 2011). Ninety minute bouts or more
of consecutive zero counts were classiﬁed as non-wear time; during
these periods, intervals of up to 2min of non-zero countswere also clas-
siﬁed as non-wear time if no activity counts were detected during the
30min before and after that interval, allowing for accidentalmovement
when the accelerometerwas not beingworn. Rawdata from the vertical
axiswere integrated into 60 s epochs andused to derive counts permin-
ute (CPM). Time (minutes per day) spent sedentary and in different in-
tensities of PA were derived using standard CPM-based intensity
threshold values for older adults of b100 for sedentary behaviour,
100–1040 for LPA and N1040 for moderate-to-vigorous PA (MVPA).
Valid data required ≥3 days of ≥600 min of wear time.
3.2. Self-reported PA data
Participants self-reported their habitual PA levels, including how
often they make journeys by foot or by bike, recreational activities and
participation in sports. A total PA score was derived based on the fre-
quency and type of activity, which has previously been validated
(Wannamethee et al., 2002). Men were grouped as inactive, occasional
(regular walking or recreational activity only), light (more-frequent
recreational activities, sporting exercise less than once a week, or regu-
larwalkingplus some recreational activity),moderate (cycling, very fre-
quent weekend recreational activities plus regular walking, or sporting
activity once a week), moderately vigorous (sporting activity at least
once a week or frequent cycling, plus frequent recreational activities
or walking, or frequent sporting activities only) or vigorous (veryfrequent sporting exercise or frequent sporting exercise plus other rec-
reational activities). An additional question asked respondents to report
their engagement inmuscular strength/endurance training. This includ-
ed lifting weights, doing push-ups and using exercise machines. Partic-
ipants were classiﬁed as participating or not participating in muscular
strength and endurance training.
Participants also completed a six-item version of the Duke Activity
Status Index (DASI), which was used as a measure of general ﬁtness.
The DASI was developed to measure functional capacity and strongly
correlates with peak oxygen uptake (r = 0.80) (Hlatky et al., 1989).
The index comprised of questions regarding ability to participate in six
activities of increasing intensity, weighted according to the MET value
for each activity. A total score was calculated by adding the weighted
scores for the six items.
4. Outcome measures
4.1. Anthropometric measures
Height (cm), weight (kg), waist circumference (WC) (cm), mid-
upper arm circumference and triceps skinfold thickness (mm) were
measured as previously described (Wannamethee et al., 2007). WC
was used as a measure of obesity using a sex-speciﬁc cut point
(N102 cm) (Anon, 1998). Muscle mass was derived from the mid-
upper arm muscle circumference (MAMC) using the formula mid-
upper arm circumference − (0.3142 × triceps skinfold thickness)
(Miller et al., 2002).
4.2. Physical function and strength
Gait speed (m/s) was derived from a 3-metre walking test and was
used as a measure of physical function. Grip strength (kg) was used as
amarker ofmuscular strength andwasmeasured using a JamarHydrau-
lic Hand Dynamometer. Participants had three attempts for each hand
and the highest score was used.
4.3. Deﬁnitions of sarcopenia and sarcopenic obesity
Sarcopenia and severe sarcopenia were deﬁned using the European
Working Group on Sarcopenia in Older People (EWGSOP) deﬁnition
(Cruz-Jentoft et al., 2010). Both conditions required (i) low muscle
mass (participants in the lowest two-ﬁfths of the MAMC distribution
were classiﬁed as having low muscle mass) and either (ii) low grip
strength (b30 kg) or (iii) low gait speed (≤0.8 m/s) (Cruz-Jentoft et al.,
2010). Severe sarcopenia required the presence of all three conditions
(Cruz-Jentoft et al., 2010). To determine sarcopenia-obesity groups,
men with sarcopenia and severe sarcopenia were collapsed into an
overall sarcopenic group. They were then categorised into four groups:
non-sarcopenic non-obese (WC ≤ 102 cm, not sarcopenic), sarcopenic
non-obese (WC ≤ 102 cm, sarcopenic), non-sarcopenic obese (WC
N102 cm, not sarcopenic), or sarcopenic obese (WC N 102 cm,
sarcopenic).
5. Covariates
Men self-reported the following: social class, derived from longest
held occupation; doctor diagnosis of medical conditions including angi-
na, heart attack, heart failure, other heart conditions, bronchitis, depres-
sion, emphysema, osteoporosis, Parkinson's disease, cancer (excluding
skin cancers), arthritis and stroke; cigarette smoking habits and alcohol
intake. Number of medical conditions was categorised as low (b3) or
high (≥3) according to the abovemedical conditions. Cigarette smoking
was classiﬁed as current or recent smokers (given up in the last ten
years), ex-smokers (gave up N10 years ago) and never smokers. Alcohol
intake was classiﬁed as high (N15) or low (≤15 units of alcohol per
week).
266 D.A. Aggio et al. / Preventive Medicine 91 (2016) 264–2726. Statistical analysis
Descriptive statistics of demographic, physical health and PA vari-
ables selected a priori were calculated ﬁrstly for sarcopenia groups
and then for sacropenic obese groups. Differences between groups
were examined using one-way ANOVA and chi-square tests. Mean
and standard deviation (SD) of PA levels were calculated for quintiles
of MAMC, WC, grip strength and gait speed. Quintiles were generated
based on participants with available data on the variable of interest
after excluding participants without valid accelerometry data and
those living in care homes (sample size, n = 1521). Tests for linear
trend were conducted by entering each component of sarcopenia/
sarcopenic obesity (muscle mass, MAMC [cm]; obesity, WC [cm]; phys-
ical performance, gait speed [m/s]; muscular strength, grip strength
[kg]) continuously into regression models, adjusting for age and WC.
Multinomial logistic regressionwas used to examine the association be-
tween PA and sarcopenia categories. Exposure measures were objec-
tively measured PA variables (sedentary time [min/day], number of
breaks in sedentary time per hour, LPA [min/day], MVPA [min/day])
and strength training (y/n). The primary outcomes were (i) sarcopenia,
(ii) severe sarcopenia and (iii) sarcopenic obesity. The “non-sarcopenic”
and “non-sarcopenic non-obese” groupswere selected as reference cat-
egories in respective analyses. In an additional analysis including just
obese men, we compared the non-sarcopenic obese group with the
sarcopenic obese group by selecting the former as the reference catego-
ry. Analyses were initially adjusted for age (years), wear time, season
and region (model 1); and then for occupational social class, number
of medical conditions, smoking, alcohol and height (model 2). Model 2
also controlled for WC in analyses investigating risk of sarcopenia and
severe sarcopenia. Final models (model 3) also controlled for the
other intensities of PA i.e. MVPA was included as a covariate when ex-
amining associations of sedentary time, breaks in sedentary time and
LPA. All analyses were carried out using STATA version 12 (Stata Corp,
College Station, TX).
6.1. Sensitivity analyses
We repeated models excluding men with heart attack, heart failure
or stroke (n = 206). MVPA was positively skewed so we repeated
models using square-root-transformedMVPA to normalise the distribu-
tion. We also repeated analyses using self-reported PA and DASI ﬁtness
scores as exposures.
7. Results
1655/3137 (52.8%) of survivors agreed to take part in the physical
examination and wear an accelerometer. After excluding men who
were conﬁned to a wheelchair or resident in a care home (n = 7),
1521 (48.5%) men provided valid PA data, of whom 1286 (41.0%) had
complete data from the physical examination, functional tests and ques-
tionnaire (Fig. 1). Participants not attending this wave of data collection
or with incomplete data had a higher BMI ten years earlier (27.0 vs.
26.7 kg/m2, p b 0.05), were less active (40.9% vs. 60.3% at least moder-
ately active, p b 0.001), were more likely to smoke (20.2% vs. 11.5%,
p b 0.001) and were older (69.8 years vs. 66.0 years, p b 0.001) than
those included in the study sample (n = 1286).
183men (14.2%) were classiﬁed as sarcopenic, 70 (5.4%) as severely
sarcopenic and 1033 (80.3%) as non-sarcopenic (Table 1). Sarcopenic
and severely sarcopenicmenwere older, shorter, hadmore chronic con-
ditions, lower body weight, BMI andWC, and were generally less phys-
ically active than the reference group. The severely sarcopenic group
were the least active with 19.8 min/day of MVPA compared to
42.1 min/day in the non-sarcopenic group.
Table 2 presents participant characteristics according to sarcopenia-
obesity groups. 64 men (5.0%) were classiﬁed as sarcopenic-obese, 189
(14.7%) as sarcopenic non-obese, 442 (34.4%) as non-sarcopenic obeseand 591 (46%) as non-sarcopenic non-obese. 25.3% of individuals with
sarcopenia/severe sarcopenia were also obese. Sarcopenic obese and
sarcopenic non-obese were older, shorter, had more chronic conditions
and were less active than the non-sarcopenic non-obese group. The
sarcopenic obese group was the least active.
Table 3 presents participant PA levels by quintiles of MAMC, WC,
grip strength and gait speed. None of the PA variables were associated
with MAMC after adjustments. WC was inversely associated with
MVPA, LPA, breaks in sedentary time and participation in muscle
strengthening/endurance exercises and positively associated with sed-
entary time after adjusting for age. Gait speed and grip strength were
positively associated with MVPA and inversely associated with seden-
tary time. Gait speedwas also positively associatedwith LPA and breaks
in sedentary time. Participation inmuscle strengthening/endurance ex-
ercises was associatedwith higher grip strength but this did not remain
signiﬁcant after adjusting for WC and age.
In multinomial logistic regression models, none of the PA variables
were associated with risk of sarcopenia but they were associated with
severe sarcopenia (Table 4). Each extra 30 min of sedentary time was
associated with an increased risk of severe sarcopenia, which persisted
after adjusting for social class, number of chronic conditions, smoking,
alcohol, height and WC, but was fully attenuated after adjusting for
MVPA. Conversely, each extra 30min of MVPA and LPAwere associated
with reduced risk of severe sarcopenia. Associations remained signiﬁ-
cant after adjusting for social, health and lifestyle factors, but LPA was
no longer associated after adjusting for MVPA. The association between
MVPA and a reduced risk of severe sarcopenia remained signiﬁcant after
adjusting for sedentary time. Associations between strength training
and severe sarcopenia were not interpretable due to low numbers
with severe sarcopenia who did strength training.
Table 5 reports the risk of sarcopenic obesity categories by PA levels.
Sedentary timewas associatedwith an increased risk of sarcopenic obe-
sity independent of MVPA. Sedentary breaks, LPA andMVPAwere asso-
ciated with reduced risk of sarcopenic obesity in ﬁnal adjusted models.
Similar associationswere observed between PA variables and the risk of
non-sarcopenic obesity. Strength training was associated with a re-
duced risk of non-sarcopenic obesity and non-obese sarcopenia, al-
though the association with non-obese sarcopenia was of borderline
signiﬁcance (p = 0.06). Associations between strength training and
sarcopenic obesity were also uninterpretable due to low numbers par-
ticipating in strength training. In an additional analysis including just
obese men, the non-sarcopenic obese category was selected as the ref-
erence category and compared with the sarcopenic obese group (Sup-
plementary Table 1). After adjusting for social, health and lifestyle
factors, sedentary time was associated with an increased risk of
sarcopenic obesity (RR 1.16, 95% conﬁdence interval [CI] 1.02, 1.33)
and MVPA was associated with a reduced risk (RR 0.60, 95% CI 0.39,
0.95). Associations were not signiﬁcant after adjusting for other PA
intensities.
7.1. Sensitivity analyses
Excluding men with heart attack, heart failure or stroke and using
square-root-transformed MVPA did not alter our conclusions (data not
shown). Self-reported PA and DASI ﬁtness scores were also associated
with severe sarcopenia, non-sarcopenic obesity and sarcopenic obesity.
They were also associated with the sarcopenic and sarcopenic non-
obese groups in ﬁnal adjusted models (Supplementary Tables 2-3).
8. Discussion
In this sample of free-living older Britishmen, MVPA was associated
with a reduced risk of severe sarcopenia, independent of sedentary time
and WC. Similarly, MVPA and to a lesser extent LPA and sedentary
breaks were independently associatedwith a reduced risk of sarcopenic
obesity. Conversely, sedentary time was associated with an increased
Invited to participate, n=3137
Agreed to participate, n=1655 (52.8%)
Returned with data, n=1566 (49.9%)
53 lost/missing (1.7%)
6 faulty (0.2%)
30 returned unworn (1.0%)
With valid data, n=1528 (48.7%)
With valid anthropometric data, n=1426
(45.5%)
With valid physical performance data,
n=1356 (43.2%)
With valid questionnaire data, n=1286
(41.0%)
Not in care home/wheelchair, n=1521
(48.5%)
Fig. 1. Recruitment ﬂow chart – BRHS, 2010–12.
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and the individual components of sarcopenia and sarcopenic obesity
showed that PA was not associated withmuscle mass alone, suggesting
that PA may be more important for preserving a healthy weight, physi-
cal performance and muscular strength in older men.
Prevalence of sarcopenia and sarcopenic obesitywas lower than that
of previous studies with this cohort when they were younger (Atkins et
al., 2014a). However, the prevalence of sarcopenia and sarcopenic obe-
sity was comparable with previous waves data when we used the same
deﬁnition (data not shown) (Atkins et al., 2014a), suggesting that the
discrepancies mainly reﬂect our use of the EWGSOP diagnostic criteria
for sarcopenia (Cruz-Jentoft et al., 2010), including objective measures
of gait speed and grip strength that were previously unavailable. Never-
theless, sarcopenia was still common in the present sample and compa-
rable with the prevalence in other cohorts of a similar age (Kim et al.,
2013; Gianoudis et al., 2015).
To our knowledge, this is the ﬁrst study to explore associations of PA
with sarcopenia, severe sarcopenia and sarcopenic obesity using objec-
tively measured rather than self-reported PA. Higher MVPA was associ-
ated with signiﬁcant reductions in the risk of severe sarcopenia and
sarcopenic obesity. Our conclusions appear consistent with previous
studies using self-report and objective measures of PA (Ryu et al.,
2013; Atkins et al., 2014b; Shephard et al., 2013). In our study, each ad-
ditional 30min per day of MVPAwas associatedwith a 47% reduction in
severe sarcopenia risk. This is comparable with a recent longitudinal
study also using objectively measured PA; older Japanese men taking
N9000 steps per day had approximately half the risk of sarcopeniacompared to men taking b6700, with additional reduction in risk for
PA N3 METS (Shephard et al., 2013). However, direct comparisons be-
tween these studies are difﬁcult due to the different deﬁnitions used
for sarcopenia and different devices used to measure PA. A number of
studies deﬁning sarcopeniawithmusclemass alone have demonstrated
an association between PA and sarcopenia (Atkins et al., 2014b; Ryu et
al., 2013; Shephard et al., 2013). In this population, only when muscle
mass was combined with low muscular strength and low physical per-
formance (severe sarcopenia) were associations observed. Further-
more, none of the PA variables were associated with muscle mass
alone, but there were associations with gait speed, grip strength and
WC. Our ﬁndings are consistent with a recent study that also showed
no association between PA and muscle mass in men (Kim et al., 2015)
and a number of other studies showing positive associations between
PA and muscular strength in older populations (Hamer & Stamatakis,
2013; Kuh et al., 2005). Potentially PA may be more important for pre-
servingmuscular strength and physical function thanmusclemass in el-
derly men. Moreover, there is a body of evidence suggesting that
muscular strength is more important thanmuscle mass for cardiometa-
bolic health and physical function (Stephen & Janssen, 2009; Visser et
al., 2000). An alternative explanation may be that participants who
had sarcopenia at previous waves are more likely to have dropped out
of the study due to the increased risk of mortality, as previously report-
ed in this cohort (Atkins et al., 2014a). Thus our sample may be unrep-
resentative of the lower end of muscle mass distribution and therefore
reducing our power to detect associations between physical activity
and muscle mass.
Table 1
Participant characteristics of subjects with sarcopenia, severe sarcopenia and without sarcopenia deﬁned according to MAMC, gait speed and grip strength – BRHS, 2010–12.
Characteristic N Non-sarcopenia Sarcopenia Severe sarcopenia Between group
differences
(p value)a
N, (%, n) 1286 80.3% (1033) 14.2% (183) 5.4% (70)
Sociodemographics
Age, mean ± SD 1286 77.6 ± 4.1 79.7 ± 4.7 83.1 ± 5.2 p b 0.001
Current/recent smoker, (%, n) 1286 7.6 (78) 9.8 (18) 7.1 (5) 0.556
Moderate or heavy drinkers, (%, n) 1286 14.0 (145) 9.8 (18) 15.7 (11) 0.266
Manual workers, (%, n) 1286 44.8 (463) 44.8 (82) 57.1 (40) 0.255
Physical health
CHDb (%, n) 1286 15.5 (160) 19.1 (35) 15.7 (11) 0.465
Height (cm), mean ± SD 1286 172.1 ± 6.4 170.1 ± 7.0 167.0 ± 5.7 p b 0.001
Weight (kg), mean ± SD 1286 81.4 ± 11.9 72.8 ± 11.6 72.5 ± 12.3 p b 0.001
BMI (kg/m2), mean ± SD 1286 27.5 ± 3.7 25.1 ± 3.5 26.0 ± 4.2 p b 0.001
Waist circumference (cm), mean ± SD 1286 100.9 ± 10.7 94.5 ± 10.0 97.3 ± 12.1 p b 0.001
MAMC (cm), mean ± SD 1286 25.5 ± 2.7 21.8 ± 1.9 21.6 ± 2.1 p b 0.001
Hand grip (kg), mean ± SD 1286 32.3 ± 9.9 28.7 ± 10.1 22.2 ± 6.1 p b 0.001
Gait speed (m/s), mean ± SD 1286 0.95 ± 0.2 0.82 ± 0.2 0.62 ± 0.1 p b 0.001
Chronic conditions ≥3, (%, n) 1286 11.5 (119) 17.5 (32) 18.6 (13) p b 0.05
PA levels (mean, 95% CI)
Time sedentary (min/day) 1286 610.9 (606.0, 615.7) 614.1 (602.1, 626.1) 650.6 (632.0, 669.2) p b 0.001
Breaks in sedentary time per hour 1286 7.3 (7.2, 7.4) 7.3 (7.0, 7.6) 6.6 (6.0, 7.1) p b 0.05
Time in LPA (min/day) 1286 201.9 (198.1, 205.6) 196.4 (187.1, 205.7) 169.2 (152.5, 185.9) p b 0.001
Time in MVPA (min/day) 1286 42.1 (40.1, 44.0) 37.9 (32.8, 43.1) 19.8 (14.4, 25.1) p b 0.001
Wear time (min/day) 1286 854.8 (850.8, 858.8) 848.4 (838.3, 858.5) 839.5 (821.1, 857.9) 0.105
Participation in muscle strengthening/endurance exercises, (%, n) 1090c 12.9% (115) 10.1% (15) 7.6% (4) 0.352
CHD, coronaryheart disease; BMI, bodymass index;MAMC,mid-upper armmuscle circumference;MVPA,moderate-to-vigorous physical activity; LPA, light physical activity; CPM, counts
per minute.
a x2 for percentages, analysis of variance for means.
b Men with CHD consisted of men reporting a doctor diagnosis of a heart attack heart failure or stroke.
c Smaller sample size due to lower response on self-reported data.
Table 2
Participant characteristics according to Sarcopenic Obesity Groups – BRHS, 2010–12.
Characteristic N Non-sarcopenic
non-obese
Sarcopenic
non-obese
Non-sarcopenic
obese
Sarcopenic
obese
Between group
differences
(p value)a
N, (%, n) 1286 46.0% (591) 14.7% (189) 34.4% (442) 5.0% (64)
Sociodemographics
Age, mean ± SD 1286 77.7 ± 4.0 80.8 ± 5.2 77.5 ± 4.2 80.0 ± 4.6 p b 0.001
Current/recent smoker, (%, n) 1286 6.8 (40) 9.0 (17) 8.6 (38) 9.4 (6) 0.605
Moderate or heavy drinkers, (%, n) 1286 12.9 (76) 10.1 (19) 15.6 (69) 15.6 (10) 0.255
Manual workers, (%, n) 1286 40.8 (241) 41.3 (78) 50.2 (222) 68.8 (44) p b 0.001
Physical health
CHDb (%, n) 1286 15.4 (91) 20.1 (38) 15.6 (69) 12.5 (8) 0.368
Height (m), mean ± SD 1286 171.5 ± 6.2 169.0 ± 7.0 173.0 ± 6.5 170.0 ± 6.3 p b 0.001
Weight (kg), mean ± SD 1286 74.4 ± 7.3 68.0 ± 8.5 90.9 ± 10.2 86.6 ± 8.7 p b 0.001
BMI (kg/m2), mean ± SD 1286 25.3 ± 2.2 23.8 ± 2.5 30.4 ± 3.2 30.0 ± 2.8 p b 0.001
Waist circumference (cm), mean ± SD 1286 93.6 ± 6.1 90.6 ± 7.1 110.6 ± 7.0 109.3 ± 6.4 p b 0.001
MAMC (cm), mean ± SD 1286 24.8 ± 2.7 21.5 ± 2.1 26.4 ± 2.5 22.4 ± 1.5 p b 0.001
Hand grip (kg), mean ± SD 1286 32.5 ± 9.7 26.8 ± 10.2 32.0 ± 10.1 27.2 ± 7.9 p b 0.001
Gait speed (m/s), mean ± SD 1286 0.99 ± 0.2 0.79 ± 0.2 0.91 ± 0.2 0.72 ± 0.2 p b 0.001
Chronic conditions ≥3, (%, n) 1286 8.6 (51) 17.5 (33) 15.4 (68) 18.8 (12) p b 0.05
PA levels (mean, 95% CI)
Time sedentary (mins per day) 1286 599.1 (592.8, 605.5) 616.0 (604.1, 627.9) 626.6 (619.3, 633.9) 648.3 (629.1, 667.6) p b 0.001
Breaks in sedentary time per hour 1286 7.7 (7.5, 7.9) 7.4 (7.1, 7.7) 6.8 (6.7, 7.0) 6.2 (5.7, 6.7) p b 0.001
Time in LPA (mins per day) 1286 211.4 (206.3, 216.4) 197.5 (188.2, 206.7) 189.2 (183.7, 194.7) 163.4 (146.8, 180.1) p b 0.001
Time in MVPA (mins per day) 1286 48.5 (45.8, 51.1) 36.9 (31.8, 42.1) 33.6 (30.9, 36.2) 21.0 (15.9, 26.1) p b 0.001
Wear time (mins per day) 1286 858.9 (853.8, 864.0) 850.4 (840.7, 860.1) 849.3 (843.0, 855.6) 832.8 (812.5, 853.0) p b 0.05
Participation in muscle strengthening/endurance exercises
(%, n)
1090c 15.6 (80) 7.0 (11) 9.3 (35) 18.2 (8) p b 0.05
CHD, coronaryheart disease; BMI, bodymass index;MAMC,mid-upper armmuscle circumference;MVPA,moderate-to-vigorous physical activity; LPA, light physical activity; CPM, counts
per minute.
a x2 for percentages, analysis of variance for means.
b Men with CHD consisted of men reporting a doctor diagnosis of a heart attack heart failure or stroke.
c Smaller sample size due to lower response on self-reported data.
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Table 3
Physical activity levels across quintiles of components of sarcopenia and sarcopenic obesity (n = 1286) – BRHS, 2010–12.
Quintiles of sarcopenia and sarcopenic obesity components
MAMC (cm) ≤22.11
(n = 258)
22.11–24.21
(n = 264)
24.21–25.74
(n = 254)
25.74–27.34
(n = 253)
≥27.34
(n = 257)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Β (95% CI)a p value for
trend
(unadjusted)
Β (95% CI)a p value for
trend (WC and
age adjusted)
Time sedentary (min/day) 611.3 (84.5) 613.4 (78.5) 611.3 (80.0) 616.7 (78.9) 614.9 (79.5) 0.02 (−0.04, 0.08) 0.580 −0.01 (−0.06, 0.05) 0.821
Breaks in sedentary time/hour 7.5 (2.1) 7.4 (2.1) 7.3 (2.0) 7.1 (1.9) 7.2 (2.0) −0.12 (−0.20,−0.03) b0.05 −0.02 (−0.10, 0.05) 0.558
Time in LPA (min/day) 199.5 (64.0) 200.9 (65.9) 200.1 (59.9) 194.6 (61.0) 201.2 (62.9) −0.03 (−0.11, 0.05) 0.474 0.04 (−0.04, 0.11) 0.351
Time in MVPA (min/day)b 32.4 (42.3) 32.1 (41.4) 32.1 (40.1) 32.1 (35.1) 35.3 (41.1) −0.01 (−0.07, 0.06) 0.843 0.02 (−0.04, 0.09) 0.530
Participation in muscle
strengthening/endurance
exercises (%)
12.3 12.2 12.9 10.2 13.8 0.15 (−0.38, 0.69) 0.574 0.17 (−0.32, 0.65) 0.503
Waist circumference (cm) ≤91.15
(n = 264)
91.15–96.65
(n = 251)
96.65–101.80
(n = 257)
101.80–108.65
(n = 254)
≥108.65
(n = 260)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Β (95% CI)a p value for
trend
(unadjusted)
Β (95% CI)a p value for
trend (age
adjusted)
Time sedentary (min/day) 612.8 (86.4) 591.4 (76.1) 604.5 (75.1) 621.5 (80.7) 636.5 (75.2) 0.64 (0.42, 0.86) b0.001 0.74 (0.52, 0.96) b0.001
Breaks in sedentary time/hour 7.6 (2.2) 7.8 (2.0) 7.4 (2.0) 7.1 (1.9) 6.4 (1.8) −1.37 (−1.66,−1.09) b0.001 −1.51 (−1.80,−1.22) b0.001
Time in LPA (min/day) 204.9 (66.6) 213.9 (58.7) 205.4 (61.8) 199.0 (63.1) 173.8 (55.8) −1.13 (−1.41,−0.85) b0.001 −1.29 (−1.57,−1.01) b0.001
Time in MVPA (min/day)b 38.2 (40.7) 44.6 (52.0) 33.7 (38.1) 27.0 (37.0) 22.1 (32.8) −1.03 (−1.26,−0.80) b0.001 −1.36 (−1.60,−1.11) b0.001
Participation in muscle
strengthening/endurance
exercises (%)
14.8 11.8 14.1 11.1 9.5 −1.72 (−3.69, 0.24) 0.086 −2.08 (−4.04,−0.11) b0.05
Gait speed (m/s) ≤0.73
(n = 249)
0.73–0.86
(n = 270)
0.86–0.97
(n = 259)
0.97–1.10
(n = 257)
≥1.10
(n = 251)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Β (95% CI)a p value for
trend
(unadjusted)
Β (95% CI)a p value for
trend (WC and
age adjusted)
Time sedentary (min/day) 636.1 (80.2) 624.2 (81.4) 613.4 (83.8) 603.2 (71.0) 590.2 (76.4) −0.02 (−0.02,−0.01) b0.001 −0.01 (−0.02,−0.01) b0.001
Breaks in sedentary time/hour 6.6 (2.2) 7.0 (2.0) 7.4 (1.8) 7.7 (1.9) 7.8 (2.0) 0.03 (0.02, 0.03) b0.001 0.02 (0.01, 0.02) b0.001
Time in LPA (min/day) 172.2 (68.9) 189.5 (63.0) 203.5 (55.9) 211.1 (57.7) 220.2 (56.4) 0.03 (0.03, 0.04) b0.001 0.02 (0.02, 0.03) b0.001
Time in MVPA (min/day)b 13.2 (24.3) 26.6 (34.9) 34.1 (38.4) 37.6 (40.9) 47.7 (36.4) 0.04 (0.03, 0.04) b0.001 0.03 (0.02, 0.03) b0.001
Participation in muscle
strengthening/endurance
exercises (%)
9.3 12.8 12.9 14.6 11.5 0.03 (−0.02, 0.07) 0.209 0.00 (−0.04, 0.04) 0.846
Grip strength (kg) ≤22
(n = 253)
22–30
(n = 282)
30–34
(n = 246)
34–40
(n = 317)
≥40
(n = 248)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Β (95% CI)a p value for
trend
(unadjusted)
Β (95% CI)a p value for
trend (WC and
age adjusted)
Time sedentary (min/day) 622.6 (84.2) 622.8 (80.1) 607.8 (78.8) 610.8 (81.5) 599.2 (71.7) −0.35 (−0.56,−0.14) b0.05 -0.20 (−0.41, 0.01) 0.062
Breaks in sedentary time/hour 7.1 (2.1) 7.1 (2.0) 7.4 (2.1) 7.4 (1.9) 7.5 (1.9) 0.31 (0.03, 0.58) b0.05 0.14 (−0.14, 0.42) 0.329
Time in LPA (min/day) 193.8 (63.8) 189.4 (63.8) 202.2 (62.3) 202.6 (60.7) 212.1 (61.5) 0.41 (0.15, 0.67) b0.05 0.21 (−0.06, 0.48) 0.125
Time in MVPA (min/day)b 23.9 (36.1) 24.9 (37.9) 35.4 (41.6) 37.5 (38.6) 46.2 (39.1) 0.79 (0.57, 1.00) b0.001 0.58 (0.34, 0.82) b0.001
Participation in muscle
strengthening/endurance
exercises (%)
10.3 11.2 10.5 14.2 15.8 1.86 (0.05, 3.68) b0.05 1.19 (−0.59, 2.97) 0.189
MVPA, moderate-to-vigorous physical activity; CPM, counts per minute; LPA, light physical activity.
a Linear trend regression coefﬁcient. For regression analyses time sedentary, in light and in MVPA was converted to units of 30 min/day.
b Values expressed as median and interquartile range; MVPA was transformed by square rooting for regression analyses.
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Table 4
Multinomial logistic regression analysis of sarcopenia and severe sarcopenia risk according to physical activity levels (reference: non-sarcopenic group) – BRHS, 2010–12.
Non-sarcopenic Sarcopenic Severe sarcopenic
RR (95% CI) RR (95% CI) RR (95% CI)
Model 1a
Sedentary time (30 min/day) 1.00 0.99 (0.92, 1.05) 1.19 (1.06, 1.35)
Breaks in sedentary time (breaks/hour) 1.00 1.05 (0.96, 1.14) 0.92 (0.80, 1.05)
Light PA time (30 min/day) 1.00 1.02 (0.93, 1.11) 0.85 (0.73, 0.99)
MVPA time (30 min/day) 1.00 1.03 (0.87, 1.21) 0.49 (0.32, 0.76)
Strength training (no/yes)e 1.00 0.89 (0.50, 1.59)
Model 2b
Sedentary time (30 min/day) 1.00 1.03 (0.96, 1.11) 1.22 (1.07, 1.38)
Breaks in sedentary time (breaks/hour) 1.00 0.97 (0.89, 1.06) 0.88 (0.76, 1.02)
Light PA time (30 min/day) 1.00 0.98 (0.89, 1.07) 0.84 (0.72, 0.98)
MVPA time (30 min/day) 1.00 0.92 (0.77, 1.10) 0.45 (0.29, 0.72)
Strength training (no/yes)e 1.00 0.82 (0.45, 1.50)
Model 3
Sedentary time (30 min/day)c 1.00 1.01 (0.92, 1.12) 1.07 (0.91, 1.26)
Breaks in sedentary time (breaks/hour)c 1.00 0.99 (0.90, 1.08) 0.96 (0.83, 1.12)
Light PA time (30 min/day)c 1.00 0.99 (0.90, 1.09) 0.93 (0.79, 1.10)
MVPA time (30 min/day)d 1.00 0.93 (0.73, 1.19) 0.53 (0.30, 0.93)
Models 1 and 2 included only one activity variable as an exposure per regression whereas model 3 also controlled for other intensities of physical activity.
MVPA, moderate-to-vigorous physical activity; LPA, light physical activity; CPM, counts per minute; RR, risk ratio.
a Model 1 adjusted for age, wear time, season and region.
b Model 2 additionally adjusted for social class, number of chronic conditions, smoking, alcohol, height and waist circumference.
c Model 3 further adjusted for MVPA.
d Model 3 further adjusted for sedentary time.
e Risk ratios were not interpretable due to low participation in strength training in the severe sarcopenic group.
270 D.A. Aggio et al. / Preventive Medicine 91 (2016) 264–272For the ﬁrst time we demonstrated an association between objec-
tivelymeasured PA and a reduced risk of sarcopenic obesity. This is con-
sistent with studies using self-reported PA (Ryu et al., 2013) and ﬁtness
measures (Pedrero-Chamizo et al., 2015). Notably, we showed that
even LPA and sedentary breaks were associated with a reduced risk of
sarcopenic obesity, which appears to be driven by higher gait speed
and lower WC. Higher sedentary time was associated with increased
risk of sarcopenic obesity, independent of MVPA, which is broadly con-
sistent with other studies that have shown independent associations
between sedentary behaviour with obesity (Healy et al., 2008; Jakes etTable 5
Multinomial logistic regression analysis of sarcopenic obesity risk according to physical activity
Non-sarcopenic non-obese
RR (95% CI)
Model 1a
Sedentary time (30 min/day) 1.00
Breaks in sedentary time (breaks/hour) 1.00
Light PA time (30 min/day) 1.00
MVPA time (30 min/day) 1.00
Strength training (no/yes)e 1.00
Model 2b
Sedentary time (30 min/day) 1.00
Breaks in sedentary time (breaks/hour) 1.00
Light PA time (30 min/day) 1.00
MVPA time (30 min/day) 1.00
Strength training (no/yes)e 1.00
Model 3
Sedentary time (30 min/day)c 1.00
Breaks in sedentary time (breaks/hour)c 1.00
Light PA time (30 min/day)c 1.00
MVPA time (30 min/day)d 1.00
Models 1 and 2 included only one activity variable as an exposure per regression whereas mod
MVPA, moderate-to-vigorous physical activity; LPA, light physical activity; CPM, counts per mi
a Model 1 adjusted for age, wear time, season and region.
b Model 2 additionally adjusted for social class, number of chronic conditions, smoking, alco
c Model 3 further adjusted for MVPA.
d Model 3 further adjusted for sedentary time.
e Risk ratios were not interpretable due to low participation in strength training in the sarcoal., 2003) and sarcopenia (Gianoudis et al., 2015) as individual out-
comes. As expected, PA was strongly associated with a reduced risk of
obesity (Atkins et al., 2014a). PA was also associated with a reduced
risk of sarcopenic obesity when compared to those with just obesity,
suggesting that the presence of both conditions heightens associations
with PA. Importantly, the ‘non-sarcopenic non-obese’ reference group
demonstrate healthier behaviours than the ‘non-sarcopenic’ reference
group, whichmay explain why associations between PA and sarcopenic
obesity are more pronounced than those with sarcopenia and severe
sarcopenia.levels (reference: non-sarcopenic non-obese group) – BRHS, 2010–12.
Sarcopenic non-obese Non-sarcopenic obese Sarcopenic obese
RR (95% CI) RR (95% CI) RR (95% CI)
1.04 (0.96, 1.12) 1.23 (1.16, 1.30 1.43 (1.26, 1.62)
1.00 (0.91, 1.09) 0.79 (0.74, 0.85) 0.71 (0.61, 0.83)
0.97 (0.89, 1.07) 0.83 (0.77, 0.89) 0.71 (0.60, 0.82)
0.91 (0.76, 1.09) 0.58 (0.50, 0.67) 0.33 (0.21, 0.51)
0.50 (0.26, 0.99) 0.56 (0.36, 0.85)
1.02 (0.95, 1.10) 1.22 (1.16, 1.30) 1.40 (1.23, 1.59)
1.00 (0.92, 1.09) 0.80 (0.74, 0.86) 0.73 (0.63, 0.85)
0.99 (0.90, 1.09) 0.83 (0.77, 0.89) 0.73 (0.62, 0.85)
0.95 (0.79, 1.13) 0.58 (0.50, 0.68) 0.34 (0.21, 0.53)
0.52 (0.26, 1.03) 0.54 (0.35, 0.83)
1.00 (0.90, 1.11) 1.11 (1.02, 1.20) 1.18 (0.99, 1.40)
1.02 (0.92, 1.12) 0.86 (0.80, 0.93) 0.84 (0.71, 0.99)
1.00 (0.90, 1.11) 0.91 (0.84, 0.98) 0.85 (0.72, 1.01)
0.94 (0.74, 1.21) 0.69 (0.57, 0.84) 0.47 (0.27, 0.84)
el 3 also controlled for other intensities of physical activity.
nute; RR, risk ratio.
hol and height.
penic obese group.
271D.A. Aggio et al. / Preventive Medicine 91 (2016) 264–272Self-reported strength trainingwas associatedwith a reduced risk of
non-obese sarcopenia and non-sarcopenic obesity. Participation in
strength training was most strongly associated with WC and grip
strength. Previous studies in similar populations have also shown posi-
tive associations between PA and grip strength (Kuh et al., 2005; Hamer
& Stamatakis, 2013). A recent systematic review showed that resistance
training interventions are particularly effective for improving muscular
strength in aging adults (Cruz-Jentoft et al., 2014). Participation in
strength training was low in this sample, which may have reduced our
power to detect these associations.
One of the main strengths of this study is the use of objective mea-
sures of PA. This allowed us to investigate whether sedentary time,
breaks in sedentary time and LPA were associated with these condi-
tions. Our ﬁndings contribute evidence to the discussion about whether
PA guidelines for older people should also encourage sedentary breaks
and LPA. Whilst MVPA may be most strongly related to outcomes,
even increasing LPA and sedentary breaks may be beneﬁcial and also
more feasible in this population. Another strength is the use of muscle
mass,muscular strength andphysical performance to deﬁne sarcopenia.
According to the EWGSOP criteria these are essential components in the
diagnosis of sarcopenia (Cruz-Jentoft et al., 2010). Although there are
more precise measures of muscle mass such as dual X-ray absorptiom-
etry, MAMC is a practical and easy clinical measure of muscle mass that
is readily available in primary care settings and is recognised as a valid
measure by the American Heart Association (Cornier et al., 2011). Our
sample is from a large cohort of community-dwelling men rather than
an at risk population, increasing the generalisability of the results. How-
ever, our ﬁndings may not be generalizable to women and non-white
ethnic groups. Sarcopenia and sarcopenic obesity have also been associ-
ated with increased risk of all-cause mortality in this cohort (Atkins et
al., 2014a). Consequently participants who had sarcopenia at previous
waves are more likely to have dropped out, potentially leading to un-
derestimation of the true associations with activity levels. Further, our
sample generally displayed healthier behaviours than those excluded
from the analysis and therefore may have been more active than the
general population, potentially attenuating observed associations. The
cut points we used for deﬁning MVPA are well established and have
been validated in older adults (Copeland & Esliger, 2009). Actigraph ac-
celerometers are less accurate at differentiating between sedentary be-
haviour and LPA. Therefore, some sedentary timemay include standing
time. Nevertheless, Actigraph-measured sedentary time correlates
strongly with ActivPal measured sitting time (r = 0.76) (Healy et al.,
2011), which is a reliable measure for sitting. Finally, this investigation
is a cross-sectional study, and causality cannot be deﬁnitely determined.9. Conclusion
Objectively measured PA was associated with a reduced risk of se-
vere sarcopenia and sarcopenic obesity. PA at a moderate-to-vigorous
intensity may be the most favourable for reducing risk; however, LPA
and breaking up prolonged periods of sedentary behaviour may also
reduce the risk of sarcopenic obesity. Further longitudinal studies are
required to determine the causality of these associations.Author contributions
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